Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
DOCS 
Doximity Inc (DOCS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/15/2025: DOCS (4-star) is a STRONG-BUY. BUY since 56 days. Simulated Profits (19.96%). Updated daily EoD!
Upturn Star Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Number of Analysts
19 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $68.67
1 Year Target Price $68.67
| 5 | Strong Buy |
| 3 | Buy |
| 11 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 16.66% | Avg. Invested days 39 | Today’s Advisory Regular Buy |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 09/15/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 13.30B USD | Price to earnings Ratio 60.71 | 1Y Target Price 68.67 |
Price to earnings Ratio 60.71 | 1Y Target Price 68.67 | ||
Volume (30-day avg) 19 | Beta 1.37 | 52 Weeks Range 39.62 - 85.21 | Updated Date 09/15/2025 |
52 Weeks Range 39.62 - 85.21 | Updated Date 09/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.17 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 39.88% | Operating Margin (TTM) 37.48% |
Management Effectiveness
Return on Assets (TTM) 13.13% | Return on Equity (TTM) 24.25% |
Valuation
Trailing PE 60.71 | Forward PE 46.95 | Enterprise Value 12474748572 | Price to Sales(TTM) 22.56 |
Enterprise Value 12474748572 | Price to Sales(TTM) 22.56 | ||
Enterprise Value to Revenue 21.16 | Enterprise Value to EBITDA 50.01 | Shares Outstanding 136400000 | Shares Floating 133218613 |
Shares Outstanding 136400000 | Shares Floating 133218613 | ||
Percent Insiders 2.29 | Percent Institutions 90.53 |
Upturn AI SWOT
Doximity Inc
Company Overview
History and Background
Doximity was founded in 2010. It provides a professional networking platform for medical professionals. The company went public in June 2021.
Core Business Areas
- Marketing Solutions: Enables pharmaceutical manufacturers and healthcare systems to reach physicians and healthcare professionals with targeted marketing campaigns.
- Hiring Solutions: Connects healthcare organizations with physicians and other clinicians seeking new job opportunities.
- Telehealth Solutions: Provides secure, HIPAA-compliant video and voice calling capabilities for virtual patient care.
Leadership and Structure
The CEO is Jeff Tangney. The company has a typical corporate structure with departments like engineering, sales, marketing, and finance.
Top Products and Market Share
Key Offerings
- Doximity Network: A social network for healthcare professionals. Boasts over 80% of US physicians as members. Competitors include Sermo and QuantiaMD.
- Dialer: A telehealth solution allowing physicians to connect with patients via video and voice calls. Competitors include Teladoc Health and Amwell.
- Referral Management: Helps physicians find and connect with specialists for patient referrals. Competitors include Kyruus and Phreesia.
Market Dynamics
Industry Overview
The healthcare technology industry is rapidly growing, driven by the need for better communication, efficiency, and patient care.
Positioning
Doximity is a leading provider of digital solutions for healthcare professionals, with a strong focus on physician networking and communication.
Total Addressable Market (TAM)
Estimated TAM is several billion dollars. Doximity is well-positioned to capture a significant portion of this TAM due to its large user base and established network.
Upturn SWOT Analysis
Strengths
- Large user base of healthcare professionals
- Strong brand recognition
- Established network effects
- High engagement rates
- Profitable business model
Weaknesses
- Reliance on advertising revenue
- Potential for data privacy concerns
- Competition from larger technology companies
Opportunities
- Expansion into new markets
- Development of new products and services
- Partnerships with other healthcare organizations
- Increased adoption of telehealth
Threats
- Increased competition
- Changes in healthcare regulations
- Economic downturn
- Data breaches
Competitors and Market Share
Key Competitors
- MDGL (Medscape)
- TNDM (Teladoc Health)
- AMWL (Amwell)
Competitive Landscape
Doximity has a strong position in the physician networking market, but faces competition from larger companies with broader product portfolios. Teladoc and Amwell are telehealth platform companies and Medscape is a medical information resource.
Major Acquisitions
AuntMinnie
- Year: 2022
- Acquisition Price (USD millions): 53.7
- Strategic Rationale: AuntMinnie, a company that provides resources and content for radiologists, was acquired to provide resources to radiologists.
Growth Trajectory and Initiatives
Historical Growth: Doximity has experienced rapid revenue growth in recent years.
Future Projections: Analysts project continued revenue growth for Doximity in the coming years, driven by increased adoption of its products and services.
Recent Initiatives: Doximity has focused on expanding its product offerings and partnerships to drive future growth.
Summary
Doximity is a leading digital platform for medical professionals, boasting strong financials and a large user base. Its strength lies in physician networking, telehealth and marketing solutions. Doximity's high dependence on advertising revenue and data privacy considerations needs to be watched. Market competition could impact future growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Earnings Call Transcripts
- Analyst Reports
- Company Website
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Doximity Inc
Exchange NYSE | Headquaters San Francisco, CA, United States | ||
IPO Launch date 2021-06-24 | Co-Founder, CEO & Chairperson Mr. Jeffrey A. Tangney | ||
Sector Healthcare | Industry Health Information Services | Full time employees 830 | Website https://www.doximity.com |
Full time employees 830 | Website https://www.doximity.com | ||
Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.